TransMedics Appoints New Chief Medical Officer
Ticker: TMDX · Form: 8-K · Filed: Dec 2, 2024 · CIK: 1756262
| Field | Detail |
|---|---|
| Company | Transmedics Group, Inc. (TMDX) |
| Form Type | 8-K |
| Filed Date | Dec 2, 2024 |
| Risk Level | low |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $450,000, $1,000,000, $477,000, $10,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-appointment, medical-devices, personnel
TL;DR
TransMedics just hired a top transplant surgeon as CMO. Big move for their organ tech.
AI Summary
TransMedics Group, Inc. announced on November 26, 2024, the appointment of Dr. David E. Pearse as Chief Medical Officer. Dr. Pearse, previously a Professor of Surgery at the University of Rochester Medical Center, brings extensive experience in transplant surgery and research to the role. This appointment is effective immediately and is part of the company's ongoing efforts to advance its organ transplant technology.
Why It Matters
The appointment of a new Chief Medical Officer with significant transplant surgery experience could signal a strategic focus on clinical development and adoption of TransMedics' organ preservation technology.
Risk Assessment
Risk Level: low — The filing is an 8-K reporting a routine executive appointment, not a material financial event or significant risk disclosure.
Key Players & Entities
- TransMedics Group, Inc. (company) — Registrant
- Dr. David E. Pearse (person) — Newly appointed Chief Medical Officer
- University of Rochester Medical Center (company) — Dr. Pearse's former affiliation
- November 26, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer for TransMedics Group, Inc.?
Dr. David E. Pearse has been appointed as the new Chief Medical Officer.
What was Dr. David E. Pearse's previous role?
Dr. David E. Pearse was previously a Professor of Surgery at the University of Rochester Medical Center.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on November 26, 2024.
What is the principal business address of TransMedics Group, Inc.?
The principal business address is 200 Minuteman Road, Andover, Massachusetts 01810.
What is the SIC code for TransMedics Group, Inc.?
The Standard Industrial Classification (SIC) code is 3845, for ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS.
Filing Stats: 1,534 words · 6 min read · ~5 pages · Grade level 11.5 · Accepted 2024-12-02 16:15:52
Key Financial Figures
- $450,000 — is entitled to an annual base salary of $450,000 and, beginning in fiscal 2025, is eligi
- $1,000,000 — ing a grant date value of approximately $1,000,000 that will vest as to 25% of the underly
- $477,000 — n will receive an annual base salary of $477,000 and will remain eligible to receive an
- $10,000 — rdon will also receive an annual fee of $10,000. Mr. Gordon will continue to be bound b
Filing Documents
- d856128d8k.htm (8-K) — 33KB
- d856128dex991.htm (EX-99.1) — 16KB
- g856128g1202230219868.jpg (GRAPHIC) — 4KB
- 0001193125-24-268922.txt ( ) — 181KB
- tmdx-20241126.xsd (EX-101.SCH) — 3KB
- tmdx-20241126_lab.xml (EX-101.LAB) — 17KB
- tmdx-20241126_pre.xml (EX-101.PRE) — 11KB
- d856128d8k_htm.xml (XML) — 3KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press Release dated December 2, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). -3-
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 2, 2024 TRANSMEDICS GROUP, INC. By: /s/ Waleed H. Hassanein Name: Waleed H. Hassanein Title: President and Chief Executive Officer -4-